Senores Pharmaceuticals Ltd is expected to finalise the share allotment status for its initial public offering (IPO) on Thursday, December 26, after the issue closed with a robust subscription.
| Company | Value | Change | %Change |
|---|
The ₹582.11-crore IPO was overall subscribed 93.41 times on the last day of bidding on Tuesday, December 24, with bids for more than 79.72 crore shares against 85.34 lakh shares on offer.
The retail portion of the IPO was booked 89.21 times, while the non-institutional investors’ (NIIs) part was subscribed 96.11 times. The qualified institutional buyers (QIBs) booked their segment 94.66 times.
The employees subscribed their category nearly 20 times compared to the 75,000 shares set aside for them.
The mainboard issue, which opened on December 20, was made up of fresh issuance of shares worth ₹500 crore and an offer for sale (OFS) of ₹82.11 crore.
The investors who bid for the IPO shares can check the allotment status online via the websites of the BSE, NSE and the issue registrar, Link Intime India Pvt Ltd.
Steps to check Senores Pharmaceuticals IPO share allotment status on BSE:
Steps to check Senores Pharmaceuticals IPO allotment on Link Intime India:
- Visit the IPO allotment status page on the official website at https://linkintime.co.in/Initial_Offer/public-issues.html.
- Select ‘Senores Pharmaceuticals Ltd’ from the list of companies.
- Select any one of these — PAN, Application Number, DP/Client ID or account number/IFSC.
- Enter the details as per your selection.
- Click on ‘Submit’ to check the allotment status.
Investors can also check the IPO allotment status on the NSE website, using the PAN and application number. The new users should register on the NSE website to check the share allocation details.
Senores Pharmaceuticals IPO details
The Senores Pharmaceuticals IPO comprised a fresh issue of 1.28 crore shares and an OFS portion of 21 lakh shares. The IPO price band was fixed at ₹372 to ₹391 per share.
After finalising the share allotment status, the company will initiate refunds and transfer of shares to the Demat accounts on Friday, December 27.
Shares of Senores Pharmaceuticals Ltd are scheduled to be listed on the NSE and BSE on December 30.
Senores Pharmaceuticals plans to utilise the IPO proceeds for setting up a manufacturing facility for production of sterile injections in its Atlanta facility. A portion of the funds will also be used for the working capital requirements of the company and its subsidiaries.
Senores Pharmaceuticals is a manufacturer of a wide range of speciality, underserved and complex pharmaceutical products. The company has several products in major therapeutic segments, including antibiotics, anti-bacterial, anti-fungal and blood line.
ALSO READ | DAM Capital Advisors IPO: GMP surges on strong demand; Issue booked 81.88x on Day 3
As of March 2024, the company had three R&D facilities in India and the United States.
ALSO READ | Unimech Aerospace IPO: Should you subscribe to the ₹500 crore issue opening today?
(Edited by : Shoma Bhattacharjee)
